The Virtual Investor "What This Means” segment featuring Outlook Therapeutics is now available here.

The spokesperson said the Commission on Human Medicines had "thoroughly examined all the available evidence and concluded that prescribing puberty blockers to children for the purposes of gender ...

A councillor has quit the Labour Party in a row over its transgender policies. Zoe Hughes, Exeter City Council member, said ...

Regulatory ApprovalFormycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® 08.01.2025 / 14:30 CET/CESTThe issuer is solely ...

Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi ® approved by Health Canada for both subcutaneous and intravenous ...

The Government said that an independent report by the Commission on Human Medicines found that there is “currently an unacceptable safety risk in the continued prescription of puberty blockers ...

UK Health Secretary Wes Streeting told MPs he was extending the temporary ban introduced in May following a consultation and advice from the Commission on Human Medicines. Streeting called the way ...

The Department of Health and Social Care (DHSC) said the Commission on Human Medicines (CHM) had published independent expert advice that there is "currently an unacceptable safety risk in the ...

It follows a consultation on the measures and independent advice from the Commission on Human Medicines (CHM) which found an ‘unacceptable safety risk’ in the continued prescription of puberty ...

According to the statement, the decision is based on “independent expert advice from the Commission on Human Medicines (CHM),” which has determined “there is currently an unacceptable safety ...

Mr Streeting announced an indefinite ban on the prescription of puberty blockers to children after the Commission on Human Medicines found there is “an unacceptable safety risk in the continued ...